Biblio

Export 1187 results:
Author [ Title(Asc)] Type Year
Filters: First Letter Of Last Name is D  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
S
N. D. DiProspero, Keator, D. B., Phelan, M., van Erp, T. G. M., Doran, E., Powell, D. K., Van Pelt, K. L., Schmitt, F. A., Head, E., Lott, I. T., and Yassa, M. A., “Selective Impairment of Long-Range Default Mode Network Functional Connectivity as a Biomarker for Preclinical Alzheimer's Disease in People with Down Syndrome.”, J Alzheimers Dis, vol. 85, no. 1, pp. 153-165, 2021.
B. C. M. Stephan, Birdi, R., Tang, E. Yee Hing, Cosco, T. D., Donini, L. M., Licher, S., M Ikram, A., Siervo, M., and Robinson, L., “Secular Trends in Dementia Prevalence and Incidence Worldwide: A Systematic Review.”, J Alzheimers Dis, vol. 66, no. 2, pp. 653-680, 2018.
C. Contini, Serrao, S., Manconi, B., Olianas, A., Iavarone, F., Bizzarro, A., Masullo, C., Castagnola, M., Messana, I., Diaz, G., and Cabras, T., “Salivary Proteomics Reveals Significant Changes in Relation to Alzheimer's Disease and Aging.”, J Alzheimers Dis, vol. 89, no. 2, pp. 605-622, 2022.
X. Hua, Church, K., Walker, W., L'Hostis, P., Viardot, G., Danjou, P., Hendrix, S., and Moebius, H. J., “Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Positive Modulator of HGF/MET, Fosgonimeton, in Healthy Volunteers and Subjects with Alzheimer's Disease: Randomized, Placebo-Controlled, Double-Blind, Phase I Clinical Trial.”, J Alzheimers Dis, vol. 86, no. 3, pp. 1399-1413, 2022.
M. Pejstrup Agger, Danielsen, E. Rubæk, Carstensen, M. Schultz, N Nguyen, M., Horning, M., Henney, M. Alexander, Jensen, C. Boe Ravn, Baandrup, A. Ohlhues, Kjær, T. Wesenberg, Madsen, K. Hougaard, Miskowiak, K., Petersen, P. Michael, and Høgh, P., “Safety, Feasibility, and Potential Clinical Efficacy of 40 Hz Invisible Spectral Flicker versus Placebo in Patients with Mild-to-Moderate Alzheimer's Disease: A Randomized, Placebo-Controlled, Double-Blinded, Pilot Study.”, J Alzheimers Dis, vol. 92, no. 2, pp. 653-665, 2023.
R
C. Cerami, Dodich, A., Greco, L., Iannaccone, S., Magnani, G., Marcone, A., Pelagallo, E., Santangelo, R., Cappa, S. F., and Perani, D., “The Role of Single-Subject Brain Metabolic Patterns in the Early Differential Diagnosis of Primary Progressive Aphasias and in Prediction of Progression to Dementia.”, J Alzheimers Dis, vol. 55, no. 1, pp. 183-197, 2017.
C. Cupidi, Frangipane, F., Gallo, M., Clodomiro, A., Colao, R., Bernardi, L., Anfossi, M., Conidi, M. Elena, Vasso, F., Curcio, S. Anna Maria, Mirabelli, M., Smirne, N., Torchia, G., Muraca, M. Gabriella, Puccio, G., Di Lorenzo, R., Zampieri, S., Romanello, M., Dardis, A., Maletta, R. Giovanni, and Bruni, A. Cecilia, “Role of Niemann-Pick Type C Disease Mutations in Dementia.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1249-1259, 2017.
C. Cupidi, Frangipane, F., Gallo, M., Clodomiro, A., Colao, R., Bernardi, L., Anfossi, M., Conidi, M. Elena, Vasso, F., Curcio, S. Anna Maria, Mirabelli, M., Smirne, N., Torchia, G., Muraca, M. Gabriella, Puccio, G., Di Lorenzo, R., Zampieri, S., Romanello, M., Dardis, A., Maletta, R. Giovanni, and Bruni, A. Cecilia, “Role of Niemann-Pick Type C Disease Mutations in Dementia.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1249-1259, 2017.
R. Piccarducci, Caselli, M. Chiara, Zappelli, E., Ulivi, L., Daniele, S., Siciliano, G., Ceravolo, R., Mancuso, M., Baldacci, F., and Martini, C., “The Role of Amyloid-β, Tau, and α-Synuclein Proteins as Putative Blood Biomarkers in Patients with Cerebral Amyloid Angiopathy.”, J Alzheimers Dis, vol. 89, no. 3, pp. 1039-1049, 2022.
W. Gulisano, Maugeri, D., Baltrons, M. A., Fà, M., Amato, A., Palmeri, A., D'Adamio, L., Grassi, C., Devanand, D. P., Honig, L. S., Puzzo, D., and Arancio, O., “Role of Amyloid-β and Tau Proteins in Alzheimer's Disease: Confuting the Amyloid Cascade.”, J Alzheimers Dis, vol. 64, no. s1, pp. S611-S631, 2018.
W. Gulisano, Maugeri, D., Baltrons, M. A., Fà, M., Amato, A., Palmeri, A., D'Adamio, L., Grassi, C., Devanand, D. P., Honig, L. S., Puzzo, D., and Arancio, O., “Role of Amyloid-β and Tau Proteins in Alzheimer's Disease: Confuting the Amyloid Cascade.”, J Alzheimers Dis, vol. 64, no. s1, pp. S611-S631, 2018.
H. Kim, Levine, A., Cohen, D., Gehrman, P., Zhu, X., Devanand, D. P., Lee, S., and Goldberg, T. E., “The Role of Amyloid, Tau, and APOE Genotype on the Relationship Between Informant-Reported Sleep Disturbance and Alzheimer's Disease Risks.”, J Alzheimers Dis, vol. 87, no. 4, pp. 1567-1580, 2022.
A. Macedo, Gómez, C., Rebelo, M. Ângelo, Poza, J., Gomes, I., Martins, S., Maturana-Candelas, A., de Pablo, V. Gutiérrez, Durães, L., Sousa, P., Figueruelo, M., Rodriguez, M., Pita, C., Arenas, M., Alvarez, L., Hornero, R., Lopes, A. M., and Pinto, N., “Risk Variants in Three Alzheimer's Disease Genes Show Association with EEG Endophenotypes.”, J Alzheimers Dis, vol. 80, no. 1, pp. 209-223, 2021.
A. Macedo, Gómez, C., Rebelo, M. Ângelo, Poza, J., Gomes, I., Martins, S., Maturana-Candelas, A., de Pablo, V. Gutiérrez, Durães, L., Sousa, P., Figueruelo, M., Rodriguez, M., Pita, C., Arenas, M., Alvarez, L., Hornero, R., Lopes, A. M., and Pinto, N., “Risk Variants in Three Alzheimer's Disease Genes Show Association with EEG Endophenotypes.”, J Alzheimers Dis, vol. 80, no. 1, pp. 209-223, 2021.
F. E. Taragano, Allegri, R. F., Heisecke, S. L., Martelli, M. I., Feldman, M. L., Sánchez, V., García, V. A., Tufro, G., Castro, D. M., Leguizamón, P. Perez, Guelar, V., Ruotolo, E., Zegarra, C., and Dillon, C., “Risk of Conversion to Dementia in a Mild Behavioral Impairment Group Compared to a Psychiatric Group and to a Mild Cognitive Impairment Group.”, J Alzheimers Dis, vol. 62, no. 1, pp. 227-238, 2018.
A. Elias, Cummins, T., Tyrrell, R., Lamb, F., Doré, V., Williams, R., Rosenfeld, J. V., Hopwood, M., Villemagne, V. L., and Rowe, C. C., “Risk of Alzheimer's Disease in Obstructive Sleep Apnea Syndrome: Amyloid-β and Tau Imaging.”, J Alzheimers Dis, vol. 66, no. 2, pp. 733-741, 2018.
S. P. Poulin, Bergeron, D., and Dickerson, B. C., “Risk Factors, Neuroanatomical Correlates, and Outcome of Neuropsychiatric Symptoms in Alzheimer's Disease.”, J Alzheimers Dis, vol. 60, no. 2, pp. 483-493, 2017.
L. C. Silbert, Lahna, D., Promjunyakul, N. - O., Boespflug, E., Ohya, Y., Higashiuesato, Y., Nishihira, J., Katsumata, Y., Tokashiki, T., and Dodge, H. H., “Risk Factors Associated with Cortical Thickness and White Matter Hyperintensities in Dementia Free Okinawan Elderly.”, J Alzheimers Dis, vol. 63, no. 1, pp. 365-372, 2018.
I. Beheshti, Olya, H. G. T., and Demirel, H., “Risk Assessment of Alzheimer's Disease using the Information Diffusion Model from Structural Magnetic Resonance Imaging.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1335-42, 2016.
H. Ulugut Erkoyun, van der Lee, S. J., Nijmeijer, B., van Spaendonk, R., Nelissen, A., Scarioni, M., Dijkstra, A., Samancı, B., Gürvit, H., Yıldırım, Z., Tepgeç, F., Bilgic, B., Barkhof, F., Rozemuller, A., van der Flier, W. M., Scheltens, P., Cohn-Hokke, P., and Pijnenburg, Y., “The Right Temporal Variant of Frontotemporal Dementia Is Not Genetically Sporadic: A Case Series.”, J Alzheimers Dis, vol. 79, no. 3, pp. 1195-1201, 2021.
A. Furtado, Astaburuaga, R., Costa, A., Duarte, A. C., Gonçalves, I., Cipolla-Neto, J., Lemos, M. C., Carro, E., Relógio, A., Santos, C. R. A., and Quintela, T., “The Rhythmicity of Clock Genes is Disrupted in the Choroid Plexus of the APP/PS1 Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 77, no. 2, pp. 795-806, 2020.
M. Vassilaki, Crowson, C. S., Iii, J. M. Davis, Duong, S. Q., Jones, D. T., Nguyen, A., Mielke, M. M., Vemuri, P., and Myasoedova, E., “Rheumatoid Arthritis, Cognitive Impairment, and Neuroimaging Biomarkers: Results from the Mayo Clinic Study of Aging.”, J Alzheimers Dis, vol. 89, no. 3, pp. 943-954, 2022.
E. Andreadou, Pantazaki, A. A., Daniilidou, M., and Tsolaki, M., “Rhamnolipids, Microbial Virulence Factors, in Alzheimer's Disease.”, J Alzheimers Dis, vol. 59, no. 1, pp. 209-222, 2017.
H. Hampel, Toschi, N., Babiloni, C., Baldacci, F., Black, K. L., Bokde, A. L. W., Bun, R. S., Cacciola, F., Cavedo, E., Chiesa, P. A., Colliot, O., Coman, C. - M., Dubois, B., Duggento, A., Durrleman, S., Ferretti, M. - T., George, N., Genthon, R., Habert, M. - O., Herholz, K., Koronyo, Y., Koronyo-Hamaoui, M., Lamari, F., Langevin, T., Lehéricy, S., Lorenceau, J., Neri, C., Nisticò, R., Nyasse-Messene, F., Ritchie, C., Rossi, S., Santarnecchi, E., Sporns, O., Verdooner, S. R., Vergallo, A., Villain, N., Younesi, E., Garaci, F., and Lista, S., “Revolution of Alzheimer Precision Neurology. Passageway of Systems Biology and Neurophysiology.”, J Alzheimers Dis, vol. 64, no. s1, pp. S47-S105, 2018.
H. Hampel, Toschi, N., Babiloni, C., Baldacci, F., Black, K. L., Bokde, A. L. W., Bun, R. S., Cacciola, F., Cavedo, E., Chiesa, P. A., Colliot, O., Coman, C. - M., Dubois, B., Duggento, A., Durrleman, S., Ferretti, M. - T., George, N., Genthon, R., Habert, M. - O., Herholz, K., Koronyo, Y., Koronyo-Hamaoui, M., Lamari, F., Langevin, T., Lehéricy, S., Lorenceau, J., Neri, C., Nisticò, R., Nyasse-Messene, F., Ritchie, C., Rossi, S., Santarnecchi, E., Sporns, O., Verdooner, S. R., Vergallo, A., Villain, N., Younesi, E., Garaci, F., and Lista, S., “Revolution of Alzheimer Precision Neurology. Passageway of Systems Biology and Neurophysiology.”, J Alzheimers Dis, vol. 64, no. s1, pp. S47-S105, 2018.

Pages